DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Bleomycin (Bleomycin) - Pancytopenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pancytopenia (5)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Bleomycin where reactions include pancytopenia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Bleomycin side effects in male

Reported by a physician from Greece on 2012-08-09

Patient: male

Reactions: Pulmonary Toxicity, Dyspnoea, Haemoptysis, Haemorrhage, Pancytopenia, Pyrexia, Bone Marrow Toxicity

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Bleomycin
    Dosage: 30 mg, for 3 days
    Indication: Testis Cancer

Cisplatin
    Dosage: 50 mg/m2, days 1 and 2
    Indication: Testis Cancer

Etoposide
    Dosage: 165 mg/m2, days 1-3
    Indication: Testis Cancer



Possible Bleomycin side effects in 28 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29

Patient: 28 year old female

Reactions: Streptococcal Bacteraemia, Vomiting, Nausea, Peripheral Sensorimotor Neuropathy, Carbon Monoxide Diffusing Capacity Decreased, Pancytopenia, Febrile Neutropenia, Hypoaesthesia, Paraesthesia, Coordination Abnormal, Gait Disturbance, Renal Failure Acute

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Bleomycin
    Dosage: 15 units/m2 over 24h on day2

Cisplatin
    Dosage: 90 mg/m2 over 4h on day1
    Indication: Ovarian Cancer

Cisplatin
    Dosage: 45 mg/m 2

Cyclophosphamide
    Dosage: 1000 mg/m2 over 60min on day 2
    Indication: Ovarian Cancer

Cyclophosphamide
    Dosage: 750 mg/m 2

Doxorubicin HCL
    Dosage: 45 mg/m2 over 30min on day3
    Indication: Ovarian Cancer

Doxorubicin HCL
    Dosage: 30 mg/m 2

Etoposide
    Dosage: 200 mg/m2 over 2h on day3
    Indication: Ovarian Cancer

Etoposide
    Dosage: 100 mg/m 2

Vinblastine
    Dosage: 6mg/m2 over 30min on day1
    Indication: Ovarian Cancer

Other drugs received by patient: Pegfilgrastim



Possible Bleomycin side effects in 24 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-28

Patient: 24 year old female

Reactions: Mucosal Inflammation, Cellulitis, Pancytopenia

Drug(s) suspected as cause:
Bleomycin
    Dosage: 15 units/m2 over 24 hours on d2
    Indication: Ovarian Cancer

Cisplatin
    Dosage: 90 mg/m2, over 4h on d1
    Indication: Ovarian Cancer

Cyclophosphamide
    Dosage: 1000 mg/m2 over 60 min on d2
    Indication: Ovarian Cancer

Doxorubicin HCL
    Dosage: 45 mg/m2 over 30 min on d3
    Indication: Ovarian Cancer

Etoposide
    Dosage: 200 mg/m2 over 2h on d3
    Indication: Ovarian Cancer

Vinblastine Sulfate
    Dosage: 6 mg/m2 over 30 min on d1
    Indication: Ovarian Cancer

Other drugs received by patient: Pegfilgrastim



Possible Bleomycin side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-24

Patient:

Reactions: Pancytopenia

Drug(s) suspected as cause:
Bleomycin
    Dosage: 10u/m2
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: on day 4
    Indication: Hodgkin's Disease

Interferon Alfa
    Dosage: daily for 3 days prior to chemotherapy and on day 4
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Indication: Hodgkin's Disease



Possible Bleomycin side effects in male

Reported by a physician from Greece on 2012-02-09

Patient: male

Reactions: Myelodysplastic Syndrome, Pancytopenia, Refractory Cytopenia With Multilineage Dysplasia

Drug(s) suspected as cause:
Bleomycin
    Indication: Hodgkin's Disease
    Start date: 2000-01-01
    End date: 2001-08-01

Carmustine
    Indication: Stem Cell Transplant
    Start date: 2002-05-01

Chlormethine
    Indication: Hodgkin's Disease
    Start date: 2000-01-01
    End date: 2001-08-01

Cisplatin
    Indication: Hodgkin's Disease
    Start date: 2002-01-01
    End date: 2002-01-01

Cyclophosphamide
    Indication: Hodgkin's Disease
    Start date: 2000-01-01
    End date: 2001-08-01

Cytarabine
    Indication: Stem Cell Transplant
    Start date: 2002-05-01

Dacarbazine
    Indication: Hodgkin's Disease
    Start date: 2000-01-01
    End date: 2001-08-01

Dexamethasone
    Indication: Hodgkin's Disease
    Start date: 2002-01-01
    End date: 2002-01-01

Doxorubicin HCL
    Indication: Hodgkin's Disease
    Start date: 2000-01-01
    End date: 2001-08-01

Etoposide
    Indication: Hodgkin's Disease
    Start date: 2002-01-01
    End date: 2002-01-01

Ifosfamide
    Indication: Hodgkin's Disease
    Start date: 2002-01-01
    End date: 2002-01-01

Melphalan Hydrochloride
    Indication: Stem Cell Transplant
    Start date: 2002-05-01

Prednisolone
    Indication: Hodgkin's Disease
    Start date: 2000-01-01
    End date: 2001-08-01

Prednisone
    Indication: Hodgkin's Disease
    Start date: 2000-01-01
    End date: 2001-08-01

Procarbazine Hydrochloride
    Indication: Hodgkin's Disease
    Start date: 2000-01-01
    End date: 2001-08-01

Radiotherapy
    Indication: Hodgkin's Disease
    Start date: 2000-01-01
    End date: 2001-08-01

Vinblastine Sulfate
    Indication: Hodgkin's Disease
    Start date: 2000-01-01
    End date: 2001-08-01

Vincristine
    Indication: Hodgkin's Disease
    Start date: 2000-01-01
    End date: 2001-08-01

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017